IART Q1 2024 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$738M

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$369M-3.1% YoY

Gross Profit

$207M56.1% margin

Operating Income

$4M1.1% margin

Net Income

-$3M-0.9% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

-7.1%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$291,000

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$4.1B

Total Liabilities

$2.5B

Stockholders' Equity

$1.6B

Cash & Equivalents

$592M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$369M	$381M	-3.1%
Gross Profit	$207M	$233M	-11.2%
Operating Income	$4M	$36M	-89.1%
Net Income	-$3M	$24M	-113.5%

Revenue Segments

Codman Specialty Surgical

$256M70%

Tissue Technologies

$112M30%

Geographic Segments

UNITED STATES

$256M69%

Asia Pacific

$50M13%

Europe

$42M11%

Rest Of World

$22M6%